Law.com Subscribers SAVE 30%

Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.

Search


Movers & Shakers
October 30, 2007
News about lawyers and law firms in the franchising industry.
New Briefs
October 30, 2007
Highlights of the latest franchising news from around the country.
Court Watch
October 30, 2007
Highlights of the latest franchising cases from around the country.
Injunctions in Franchising: Comparing the Canadian and American Systems
October 30, 2007
This month's installment continues an exploration of the differences that franchisors in the United States and Canada will face when seeking injunctions to enforce non-competition and other covenants contained in their franchise agreements.
Supplemental Bonuses
October 29, 2007
New York's Sullivan & Cromwell LLP plans to pay counsels and senior associates (fifth-year level and up) bonuses tied to the firm's financial performance.
An Upbeat View: Nonlawyer Ownership of Law Firms
October 29, 2007
This article examines the two main objections to outside ownership of law firms. The first is that it would permit nonlawyers to interfere with lawyers' exercise of professional judgment. The second is that the firm's duty to its shareholders would lead it to focus blindly on maximizing profits.
How Nonlawyer Ownership Abroad May Affect U.S. Firms
October 29, 2007
This commentary provides some preliminary thoughts on how equity investments in non-U.S. law firms may change how U.S. law firms do business.
The Uncertain Tax Status of Series LLCs
October 29, 2007
The Internal Revenue Service has not weighed in on the proper tax classification of series LLCs. Accordingly, lawyers recommending this new form of entity to clients or considering a series LLC for an ancillary business of the law firm or other purpose should proceed with caution.
Case Notes
October 29, 2007
Highlights of the latest product liability cases from around the country.
Prescription Drugs: Consumer Fraud in Sales and Marketing
October 29, 2007
Claims of consumer fraud are difficult and rarely succeed in the context of a pharmaceutical product liability action. They are, however, troublesome, because the pleading of such a claim often opens the door to extensive discovery of the company's sales and marketing departments. If the defendant cannot succeed in obtaining a dismissal prior to trial, it may still permit the jury to hear evidence of sales tactics and strategies that often paint the manufacturer in a less-than-favorable light. Companies should be aware of the potential for such claims and plan their sales and marketing strategies accordingly.

MOST POPULAR STORIES